Discussed On
Episodes
On The Pen GLP-1 News · May 5, 2026
He Took Retatrutide 40mg and Proved a Point
Gray market GLP-1 access and safety risksRetatrutide dosing errors and adverse eventsFoundae (orfoglutide) liver safety signalsRegulatory enforcement against compounded GLP-1sState medical board pressure on clinicians
View Analysis